These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 19766477

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Single nucleotide polymorphisms in chromosomal instability genes and risk and clinical outcome of breast cancer: a Swedish prospective case-control study.
    Brendle A, Brandt A, Johansson R, Enquist K, Hallmans G, Hemminki K, Lenner P, Försti A.
    Eur J Cancer; 2009 Feb; 45(3):435-42. PubMed ID: 19008095
    [Abstract] [Full Text] [Related]

  • 5. Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis.
    Försti A, Jin Q, Altieri A, Johansson R, Wagner K, Enquist K, Grzybowska E, Pamula J, Pekala W, Hallmans G, Lenner P, Hemminki K.
    Breast Cancer Res Treat; 2007 Jan; 101(1):83-93. PubMed ID: 16807673
    [Abstract] [Full Text] [Related]

  • 6. Breast cancer survival is associated with telomere length in peripheral blood cells.
    Svenson U, Nordfjäll K, Stegmayr B, Manjer J, Nilsson P, Tavelin B, Henriksson R, Lenner P, Roos G.
    Cancer Res; 2008 May 15; 68(10):3618-23. PubMed ID: 18483243
    [Abstract] [Full Text] [Related]

  • 7. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer.
    Broberg K, Björk J, Paulsson K, Höglund M, Albin M.
    Carcinogenesis; 2005 Jul 15; 26(7):1263-71. PubMed ID: 15746160
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression.
    Lei H, Hemminki K, Altieri A, Johansson R, Enquist K, Hallmans G, Lenner P, Försti A.
    Breast Cancer Res Treat; 2007 May 15; 103(1):61-9. PubMed ID: 17033924
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. PAI-1 -675 4G/5G polymorphism as a prognostic biomarker in breast cancer.
    Lei H, Hemminki K, Johansson R, Altieri A, Enquist K, Henriksson R, Lenner P, Försti A.
    Breast Cancer Res Treat; 2008 May 15; 109(1):165-75. PubMed ID: 17616807
    [Abstract] [Full Text] [Related]

  • 13. Genetic variation in five genes important in telomere biology and risk for breast cancer.
    Savage SA, Chanock SJ, Lissowska J, Brinton LA, Richesson D, Peplonska B, Bardin-Mikolajczak A, Zatonski W, Szeszenia-Dabrowska N, Garcia-Closas M.
    Br J Cancer; 2007 Sep 17; 97(6):832-6. PubMed ID: 17848914
    [Abstract] [Full Text] [Related]

  • 14. Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients.
    Fasching PA, Loehberg CR, Strissel PL, Lux MP, Bani MR, Schrauder M, Geiler S, Ringleff K, Oeser S, Weihbrecht S, Schulz-Wendtland R, Hartmann A, Beckmann MW, Strick R.
    Breast Cancer Res Treat; 2008 Nov 17; 112(1):89-98. PubMed ID: 18049890
    [Abstract] [Full Text] [Related]

  • 15. Cytokine gene polymorphisms and breast cancer susceptibility.
    Scola L, Vaglica M, Crivello A, Palmeri L, Forte GI, Macaluso MC, Giacalone A, Di Noto L, Bongiovanni A, Raimondi C, Accardo A, Verna R, Candore G, Caruso C, Lio D, Palmeri S.
    Ann N Y Acad Sci; 2006 Nov 17; 1089():104-9. PubMed ID: 17261759
    [Abstract] [Full Text] [Related]

  • 16. Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk.
    Langsenlehner U, Renner W, Yazdani-Biuki B, Eder T, Wascher TC, Paulweber B, Clar H, Hofmann G, Samonigg H, Krippl P.
    Breast Cancer Res Treat; 2006 May 17; 97(1):67-72. PubMed ID: 16317580
    [Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.
    Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R, Henriksson R, Chen B, Pamula J, Pekala W, Zientek H, Rogozinska-Szczepka J, Utracka-Hutka B, Hallmans G, Försti A.
    Clin Cancer Res; 2005 May 15; 11(10):3647-53. PubMed ID: 15897560
    [Abstract] [Full Text] [Related]

  • 18. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer.
    Lin X, Gu J, Lu C, Spitz MR, Wu X.
    Clin Cancer Res; 2006 Oct 01; 12(19):5720-5. PubMed ID: 17020976
    [Abstract] [Full Text] [Related]

  • 19. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
    Naidu R, Har YC, Taib NA.
    J Exp Clin Cancer Res; 2007 Mar 01; 26(1):133-40. PubMed ID: 17550142
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.